Lelo A, Miners JO, Robson RA ほか. Quantitative assessment of caffeine partial clearances in man..
British Journal of Clinical Pharmacology1986. DOI: 10.1111/j.1365-2125.1986.tb05247.x (PMID: 3756066)↩
Lelo A, Birkett DJ, Robson RA ほか. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man..
British Journal of Clinical Pharmacology1986. DOI: 10.1111/j.1365-2125.1986.tb05246.x (PMID: 3756065)↩
Yoo C, Xing D, Gonzalez DE ほか. Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run.
Journal of the International Society of Sports Nutrition2024. DOI: 10.1080/15502783.2024.2352779 (PMID: 38725238)↩
Bingol Diedhiou A, Yildirim UC, Ozdenk S ほか. Comparative effects of caffeine and paraxanthine on rowing performance and sleep quality: a randomized crossover study.
Journal of the International Society of Sports Nutrition2026. DOI: 10.1080/15502783.2026.2650339 (PMID: 41918248)↩
Szlapinski SK, Charrette A, Guthrie N ほか. Paraxanthine safety and comparison to caffeine.
Frontiers in Toxicology2023. DOI: 10.3389/ftox.2023.1117729 (PMID: 36818692)↩
Orrú M, Guitart X, Karcz-Kubicha M ほか. Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans..
Neuropharmacology2013. DOI: 10.1016/j.neuropharm.2012.11.029 (PMID: 23261866)↩